Literature DB >> 25547462

Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice.

Mano Aliczki1, Zoltan Kristof Varga, Zoltan Balogh, Jozsef Haller.   

Abstract

RATIONALE: Endocannabinoids are strong modulators of emotionality and present a novel target for psychotropic drug development. Increasing evidence suggests that endocannabinoids anandamide and 2-arachidonoylglycerol (2-AG) affect behavior differentially. While the roles of anandamide have been investigated extensively, studies regarding the specific roles of 2-AG became possible only recently, and its involvement in social behaviors has not yet been studied.
OBJECTIVE: We studied the impact of 2-AG signaling on aggression as a first attempt to characterize the role of this endocannabinoid in social behaviors.
METHODS: 2-AG signaling was enhanced by the monoacylglycerol lipase inhibitor JZL184 (8, and 16 mg/kg) in mice later submitted to the resident/intruder paradigm.
RESULTS: JZL184 near completely abolished aggressiveness in residents and increased victimization (i.e., attacks by the opponent). Interestingly, the level of defensiveness remained unaltered, despite the large increase in bites received. The CB1 receptor blocker AM251 (0.5 mg/kg) did not influence the effects of JZL184. In intruders, JZL184 near completely suppressed bites and offensive behavior in a fashion similar to residents, but it also increased agitation and defensiveness during, and the corticosterone response to, aggressive encounters. Experiments involving the corticosterone synthesis inhibitor metyrapone (30 mg/kg) suggest that the suppression of biting and offensive behavior is directly influenced by JZL184, whereas increased agitation and defensiveness (seen in intruders only) are a secondary development of the stress-endocrine effects of JZL184.
CONCLUSIONS: 2-AG signaling emerges as a surprisingly strong negative modulator of aggressiveness, which warrants further studies into its general role in social behavior and the target receptors involved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547462     DOI: 10.1007/s00213-014-3846-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.

Authors:  J Haller; B Varga; C Ledent; T F Freund
Journal:  Behav Pharmacol       Date:  2004-07       Impact factor: 2.293

2.  Post-weaning social isolation induces abnormal forms of aggression in conjunction with increased glucocorticoid and autonomic stress responses.

Authors:  Mate Toth; Eva Mikics; Aron Tulogdi; Mano Aliczki; Jozsef Haller
Journal:  Horm Behav       Date:  2011-02-21       Impact factor: 3.587

Review 3.  Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Alex Perchuk; Paul A Meozzi; Lester Myers; Zoila Mora; Patricia Tagliaferro; Eileen Gardner; Alicia Brusco; Babatunde E Akinshola; Qing-Rong Liu; Bruce Hope; Shinya Iwasaki; Tadao Arinami; Lindsey Teasenfitz; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

Review 4.  Endocannabinoid signaling in the brain.

Authors:  Rachel I Wilson; Roger A Nicoll
Journal:  Science       Date:  2002-04-26       Impact factor: 47.728

5.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

Review 6.  Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.

Authors:  Fabrício A Moreira; Maximilian Grieb; Beat Lutz
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-02       Impact factor: 4.690

7.  The integrity of the social hierarchy in mice following administration of psychotropic drugs.

Authors:  V P Poshivalov
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

8.  CB1 cannabinoid receptor-mediated aggressive behavior.

Authors:  Marta Rodriguez-Arias; Francisco Navarrete; Manuel Daza-Losada; Daniela Navarro; María A Aguilar; Pere Berbel; José Miñarro; Jorge Manzanares
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

9.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  4 in total

Review 1.  2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

Authors:  Gaurav Bedse; Mathew N Hill; Sachin Patel
Journal:  Biol Psychiatry       Date:  2020-03-17       Impact factor: 13.382

2.  Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play.

Authors:  Antonia Manduca; Olivier Lassalle; Marja Sepers; Patrizia Campolongo; Vincenzo Cuomo; Giovanni Marsicano; Brigitte Kieffer; Louk J M J Vanderschuren; Viviana Trezza; Olivier J J Manzoni
Journal:  Front Behav Neurosci       Date:  2016-11-16       Impact factor: 3.558

3.  Regulation of stress-provoked aggressive behavior using endocannabinoids.

Authors:  Chih-Hua Chang; Yu-Chen Liu; Chih-Yang Sun; Chun-Lin Su; Po-Wu Gean
Journal:  Neurobiol Stress       Date:  2021-05-13

Review 4.  The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders.

Authors:  Nathan J Kolla; Achal Mishra
Journal:  Front Behav Neurosci       Date:  2018-03-27       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.